Haleon plc (HLN) Stock Price & Analysis
Haleon plc (HLN) — MoonshotScore 78/100 (Strong band), calculated Oct 5, 2026. Price $8.80 (+0.92%), as of the Oct 2, 2026 trading session; market cap $38.8B. Expected results Mar 4, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Haleon plc · HLN · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · Haleon (HLN)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality and durable growth, at a cheap price, though the balance sheet is only middling. Business Quality: Elite; Financial Safety: Okay; Valuation: Fair; Growth Durability: Growing; Momentum: Quiet.
- quarterly revenue $7.45B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 6 of 8
- Altman Z 3.26 · Piotroski F 8
Helping: business quality, an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 78 | Strong | |
| 79 | Strong | |
| 78 | Strong | |
| 78 | Strong | |
| 79 | Strong | |
| 79 | Strong |
The score was 78 in the stored Oct 4, 2026 snapshot and remains 78 in the current publication computed Oct 5, 2026 (0). This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $8.80 | |
| Change on the day | +0.92% | |
| 52-week range | $8.65 – $11.28 | |
| Market capitalisation | $38.8B | |
| Price / earnings (trailing) | 18.10 | |
| Shares traded on the day | 22.39M | |
| Beta (volatility vs the S&P 500) | 0.25 | |
| Dividends per share (last 12 months) | $0.20 | |
| Dividend yield (last 12 months) | 2.25% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
Listen, in the second half, we expect a step-up in investment in growth, and that will show up in A&P.
Brian McNamara · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsOther perspectives
Council score for Haleon (HLN): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 24, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the HLN film — every key number, told as a short cinematic story
~2 min · open the film
What is Haleon (HLN), and what does it report?
Short answer · as of
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. Haleon plc (HLN) is listed on NYSE. Healthcare / Drug Manufacturers Specialty & Generic SEC filing business address: Building 5, First Floor, THE Heights, Weybridge, X0, KT13 0NY. It employs 24,535 people and is led by Brian James McNamara. In Q2 FY2026 it reported revenue of $7.45B and net income of $1.01B. The market values it at $38.8B.
What do the latest results show for Haleon (HLN)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $7.45B. Against analyst estimates the company has EPS beat 6 of 8 reports.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $7.52B Jul 30, 2026
- Latest report · revenue estimate
- $7.43B Jul 30, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 30, 2026
- Latest report · EPS vs estimate
- Above estimate Jul 30, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 30, 2026 | $7.52B | $7.43B | $0.2766 | $0.2669 |
| Feb 25, 2026 | $7.51B | $7.57B | $0.2597 | $0.2512 |
| Jul 31, 2025 | $7.25B | $7.48B | $0.2435 | $0.2449 |
| Feb 27, 2025 | $7.14B | $6.91B | $0.2269 | $0.2156 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $7.45B | $1.01B | $0.23 (diluted) |
| Q4 FY2025 | $7.29B | $1.13B | $0.25 (diluted) |
| Q2 FY2025 | $7.24B | $1.06B | $0.23 (diluted) |
| Q1 FY2025 | $3.62B | $532M | $0.12 (diluted) |
What are the financial strengths and risks for Haleon (HLN)?
Short answer
The MoonshotScore pillars rate business quality, an attractive price, durable growth as strengths. The distress and quality screens read Altman Z 3.26 · Piotroski F 8. Trailing ratios: ROE 6.4% · ROA 3.2% · current ratio 0.92 · earnings yield 3.3% · free-cash-flow yield 3.0%.
What should you watch next at Haleon (HLN)?
Short answer · as of
The next earnings report is expected on Mar 4, 2027.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
Listen, in the second half, we expect a step-up in investment in growth, and that will show up in A&P.
Brian McNamara ·
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
How does Haleon compare with its peers?
Short answer
Haleon's score ranks 6th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $99.96 Oct 2, 2026 | $6.51B | 91 5-pillar Oct 5, 2026 | |
| $228.30 Oct 2, 2026 | $53.5B | 88 5-pillar Oct 5, 2026 | |
| $69.69 Oct 2, 2026 | $29.2B | 87 5-pillar Oct 5, 2026 | |
| $167.77 Oct 2, 2026 | $47.4B | 84 5-pillar Oct 5, 2026 | |
| $12.25 Oct 2, 2026 | $10.2B | 81 5-pillar Oct 5, 2026 | |
| Haleon (HLN) — this page | $8.80 | $38.8B | 78 |
| $176.80 Oct 2, 2026 | $48.7B | 72 5-pillar Oct 5, 2026 | |
| $14.20 Oct 2, 2026 | $2.48B | 69 5-pillar Oct 5, 2026 | |
| $20.30 Oct 2, 2026 | $6.48B | 67 5-pillar Oct 5, 2026 | |
| $39.53 Oct 2, 2026 | $46.0B | 66 5-pillar Oct 5, 2026 | |
| $17.86 Oct 2, 2026 | $56.8B | 64 5-pillar Oct 5, 2026 | |
| $35.71 Oct 2, 2026 | $4.46B | 60 5-pillar Oct 5, 2026 | |
| $388.36 Oct 2, 2026 | $46.6B | 54 5-pillar Oct 5, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 13.2% Period end Jun 30, 2026
- Previous quarter · ownership
- 12.7% Prior to period end Jun 30, 2026
- Reporting holders
- 650 Period end Jun 30, 2026
- Previous quarter · holders
- 629 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Dodge & Cox | 149,934,507 |
| Fmr LLC | 120,991,250 |
| Clearbridge Investments, LLC | 32,342,126 |
| Morgan Stanley | 19,461,762 |
| Harris Associates L P | 16,833,252 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about Haleon (HLN)?
HLN Healthcare Stock FAQ
These answers are editorial: 1 of these 9 answers is drawn from the HLN research dossier (written Jun 14, 2026 by gpt-4o-mini); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for HLN?
HLN carries the MoonshotScore stated above — the Strong band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Haleon plc (HLN) is a leading consumer healthcare company focused on the research, development, and sale of over-the-counter products.
Is HLN a good stock to buy?
Stock Expert AI does not rate HLN buy, sell or hold. Haleon plc carries a MoonshotScore, in the Strong band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the HLN stock price today?
The last price recorded on this page for Haleon plc (HLN) is $8.80, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for HLN?
Haleon plc faces several risks, including regulatory hurdles that could delay product approvals, impacting its ability to launch new products.
What are the key factors to evaluate for HLN?
Haleon plc (HLN) holds a MoonshotScore in the high range. P/E: 18.10x. Haleon's established brand presence and distribution networks will enable it to capture a larger market share in these regions over the next five years. Not financial advice.
How frequently does HLN data refresh on this page?
HLN's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven HLN's recent stock price performance?
Haleon plc (HLN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand portfolio with high consumer recognition. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HLN overvalued or undervalued right now?
Haleon plc (HLN) trades at 18.10x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research HLN before investing?
Before investing in Haleon plc (HLN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (53 figures)
The 53 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Brian McNamara (Jul 30, 2026): Listen, in the second half, we expect a step-up in investment in growth, and that will show up in A&P. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | Building 5, First Floor, THE Heights, Weybridge, X0, KT13 0NY | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "The Heights, Weybridge, SU, KT13 0NY, GB". The FMP company description names Brentford, United Kingdom as the headquarters; this page uses the address in this row. |
FMP — 40 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $8.80 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T22:45:07.708Z. | |
px.change | Change on the day | +0.92% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $38.8B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-04T22:45:06.249Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
earn.next | Next earnings date | Mar 4, 2027 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
id.business_summary | Business description (FMP excerpt) | Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. | FMP | Financial Modeling Prep (FMP) company profile — Deterministic excerpt derived from id.description; source and date describe the input fact, not a new provider observation | |
px.change_abs | Change on the day, in dollars | +$0.08 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $7.45B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 18.10 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 22.39M | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.25 | FMP | Financial Modeling Prep (FMP) company profile | |
id.sector | Sector / industry (provider taxonomy) | Healthcare / Drug Manufacturers Specialty & Generic | FMP | Financial Modeling Prep (FMP) company profile — The company's SEC filings classify it under SIC 2844 — Perfumes, Cosmetics & Other Toilet Preparations. | |
id.employees | Employees | 24,535 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
id.ceo | Chief executive | Brian James McNamara | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
fin.q_income | Net income, Q2 FY2026 | $1.01B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
earn.history.depth.2026-07-30.revenue_actual | Revenue · reported — report date 2026-07-30 | $7.52B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-30.revenue_estimated | Revenue · estimate — report date 2026-07-30 | $7.43B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-30.eps_actual | EPS · reported — report date 2026-07-30 | $0.2766 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-30.eps_estimated | EPS · estimate — report date 2026-07-30 | $0.2669 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.revenue_actual | Revenue · reported — report date 2026-02-25 | $7.51B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.revenue_estimated | Revenue · estimate — report date 2026-02-25 | $7.57B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.eps_actual | EPS · reported — report date 2026-02-25 | $0.2597 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.eps_estimated | EPS · estimate — report date 2026-02-25 | $0.2512 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-31.revenue_actual | Revenue · reported — report date 2025-07-31 | $7.25B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-31.revenue_estimated | Revenue · estimate — report date 2025-07-31 | $7.48B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-31.eps_actual | EPS · reported — report date 2025-07-31 | $0.2435 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-31.eps_estimated | EPS · estimate — report date 2025-07-31 | $0.2449 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-27.revenue_actual | Revenue · reported — report date 2025-02-27 | $7.14B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-27.revenue_estimated | Revenue · estimate — report date 2025-02-27 | $6.91B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-27.eps_actual | EPS · reported — report date 2025-02-27 | $0.2269 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-27.eps_estimated | EPS · estimate — report date 2025-02-27 | $0.2156 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.institutions.depth.ownership_pct | Institutional ownership | 13.2% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 12.7% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 650 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 629 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Dodge & Cox — shares in provider snapshot | 149,934,507 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Fmr LLC — shares in provider snapshot | 120,991,250 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Clearbridge Investments, LLC — shares in provider snapshot | 32,342,126 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Morgan Stanley — shares in provider snapshot | 19,461,762 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Harris Associates L P — shares in provider snapshot | 16,833,252 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 4 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 6 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-09-26 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 3.26 · Piotroski F 8 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-05 | |
px.range52 | 52-week range | $8.65 – $11.28 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 6.4% · ROA 3.2% · current ratio 0.92 · earnings yield 3.3% · free-cash-flow yield 3.0% | — | UNRECORDED | Stored key metrics — Date unknown |
COMPUTED — 4 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $0.20 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 2 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 2.25% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-30.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($7.52B) with the recorded estimate ($7.43B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-30.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.2766) with the recorded estimate ($0.2669) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 3 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 78 of 100 · Strong · pillars 90 / 48 / 68 / 72 / 59 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 78 (stored snapshot Oct 4, 2026) → 78 (current publication computed Oct 5, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. | |
gap.statement_currency | Statement currency limitation | Detailed statement figures are not shown because their conversion to USD has not been verified. | OURS | Stock Expert AI currency-basis check |
Fact-family notes
- Earnings-history note. Source series as of 2026-07-30. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-30.revenue_actual,earn.history.depth.2026-07-30.revenue_estimated,earn.history.depth.2026-07-30.revenue_actual.comparison,earn.history.depth.2026-07-30.eps_actual.comparison,earn.history.depth.2026-07-30.eps_actual,earn.history.depth.2026-07-30.eps_estimated,earn.history.depth.2026-02-25.revenue_actual,earn.history.depth.2026-02-25.revenue_estimated,earn.history.depth.2026-02-25.eps_actual,earn.history.depth.2026-02-25.eps_estimated,earn.history.depth.2025-07-31.revenue_actual,earn.history.depth.2025-07-31.revenue_estimated,earn.history.depth.2025-07-31.eps_actual,earn.history.depth.2025-07-31.eps_estimated,earn.history.depth.2025-02-27.revenue_actual,earn.history.depth.2025-02-27.revenue_estimated,earn.history.depth.2025-02-27.eps_actual,earn.history.depth.2025-02-27.eps_estimated.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.
ETFs that hold HLN
Funds in our ETF coverage that list HLN among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| GMO International Quality ETF (QLTI) | 4.00% |